OPTIMIZATION OF EXPRESSION, PURIFICATION, AND STABILIZATION CONDITIONS FOR FLG-HA2-4M2E, A RECOMBINANT PROTEIN IN UNIVERSAL INFLUENZA VACCINE

QR Code

OPTIMIZATION OF EXPRESSION, PURIFICATION, AND STABILIZATION CONDITIONS FOR FLG-HA2-4M2E, A RECOMBINANT PROTEIN IN UNIVERSAL INFLUENZA VACCINE

.

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	A. A. Kovaleva, A. A. Shaldzhyan, M. V. Zaitseva, L. A. Stepanova, L. M. Tsybalova
Format:	article
Langue:	RU
Publié:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Sujets:	Infectious and parasitic diseases RC109-216
Accès en ligne:	https://doaj.org/article/7d36b6660d554fc0b97e2d8d4ebcab0f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine
par: L. M. Tsybalova, et autres
Publié: (2019)

Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tcell response in mice
par: M. A Shuklina, et autres
Publié: (2020)

GATA3 regulates FLG and FLG2 expression in human primary keratinocytes
par: Jana Zeitvogel, et autres
Publié: (2017)

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
par: Athena P. Y. Li, et autres
Publié: (2021)

IMMUNIZATION WITH UNIVERSAL INFLUENZA VACCINE ENHANCES IMMUNE RESPONSE TO SUBSEQUENT INFECTION
par: M. A. Shuklina, et autres
Publié: (2018)

Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses
par: James D. Allen, et autres
Publié: (2021)

Expression and purification of functional recombinant CUL2•RBX1 from E. coli
par: Stephanie Diaz, et autres
Publié: (2021)

Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
par: Arun B. Arunachalam, et autres
Publié: (2021)

Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles
par: Yong CY, et autres
Publié: (2015)

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
par: Christopher L. D. McMillan, et autres
Publié: (2021)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
par: D. A. Mezhenskaia, et autres
Publié: (2018)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
par: I. V. Losev, et autres
Publié: (2017)

Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.
par: Rafael Polidoro Alves Barbosa, et autres
Publié: (2013)

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
par: Daniel Stadlbauer, et autres
Publié: (2017)

Flagellar Hooks and Hook Protein FlgE Participate in Host Microbe Interactions at Immunological Level
par: Ying Shen, et autres
Publié: (2017)

The FlgN chaperone activates the Na+-driven engine of the Salmonella flagellar protein export apparatus
par: Tohru Minamino, et autres
Publié: (2021)

Production, purification and characterization of recombinant human antithrombin III by Saccharomyces cerevisiae
par: Mallu,Maheswara Reddy, et autres
Publié: (2016)

Plasticity of the Influenza Virus H5 HA Protein
par: Huihui Kong, et autres
Publié: (2021)

Асоціації SNP rs_7927894 гена FLG та TARC/CCL17 з атопічним дерматитом у дітей
par: V.O. Dityatkovsky, et autres
Publié: (2021)

Selective Purification of Recombinant Neuroactive Peptides Using the Flagellar Type III Secretion System
par: Hanna M. Singer, et autres
Publié: (2012)

Effectiveness of the Pigeon Pox Vaccine on the Chicken Vaccinated With Avian Influenza Vaccine
par: Christine A. Mikhael, et autres
Publié: (2019)

A highly efficient method for the production and purification of recombinant human CXCL8.
par: Sophie McKenna, et autres
Publié: (2021)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
par: Teddy John Wohlbold, et autres
Publié: (2015)

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
par: M. K. Erofeeva, et autres
Publié: (2014)

Development of ELISA test for the quality control of Pseudomonas aeruginosa recombinant vaccine based on the hybrid recombinant protein
par: A. V. Soldatenkova, et autres
Publié: (2020)

Electrochemical Evaluation and Phase-related Impedance Studies on Silicon–Few Layer Graphene (FLG) Composite Electrode Systems
par: Qianye Huang, et autres
Publié: (2018)

An improved fluorescent tag and its nanobodies for membrane protein expression, stability assay, and purification
par: Hongmin Cai, et autres
Publié: (2020)

IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
par: M. P. Kostinov, et autres
Publié: (2017)

Propagation, Purification and Molecular Characterization of RVF virus (ZH 501) Strain for Vaccine Production in Egyptt
par: Abo Hatab E. M., et autres
Publié: (2019)

Heterologous expression and purification of recombinant human protoporphyrinogen oxidase IX: A comparative study.
par: Zora Novakova, et autres
Publié: (2021)

Heterologous expression and purification of recombinant human protoporphyrinogen oxidase IX: A comparative study
par: Zora Novakova, et autres
Publié: (2021)

DNA removal from a purification process of recombinant hepatitis B surface antigen
par: Beldarraín Iznaga,Alejandro, et autres
Publié: (2007)

A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA
par: Sandhya Bangaru, et autres
Publié: (2018)

Serological response to influenza vaccination among children vaccinated for multiple influenza seasons.
par: Sajjad Rafiq, et autres
Publié: (2012)

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.
par: Rick A Bright, et autres
Publié: (2008)

Immune Evaluation of Recombinant Lactobacillus plantarum With Surface Display of HA1-DCpep in Mice
par: Hui Niu, et autres
Publié: (2021)

Thermostable exoshells fold and stabilize recombinant proteins
par: Siddharth Deshpande, et autres
Publié: (2017)

COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
par: N. I. Mikshis, et autres
Publié: (2018)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
par: Heni Muflihah, et autres
Publié: (2021)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection
par: Heni Muflihah, et autres
Publié: (2021)